The efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis.

Related ArticlesThe efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis. Oral Oncol. 2020 Mar 14;104:104640 Authors: Wang BC, Cao RB, Fu C, Chen WB, Li PD, Lin GH, Qian XJ, Li YT, Liu Q Abstract OBJECTIVES: There is currently no effective salvage therapeutic modality that improves the survival outcomes of patients with recurrent or metastatic nasopharyngeal...

pubmed: "oral oncol"[jour]

19h

Clinicopathological and prognostic significance of circulating tumor cells in head and neck squamous cell carcinoma: A systematic review and meta-analysis.

Related ArticlesClinicopathological and prognostic significance of circulating tumor cells in head and neck squamous cell carcinoma: A systematic review and meta-analysis. Oral Oncol. 2020 Mar 14;104:104638 Authors: Xun Y, Cao Q, Zhang J, Guan B, Wang M Abstract BACKGROUND: The prognostic significance of circulating tumor cells (CTCs) in patients with head and neck squamous cell carcinoma (HNSCC) is still unclear. The objective of this study was to estimate...

pubmed: "oral oncol"[jour]

19h

Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers.

Related ArticlesLast-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers. Oral Oncol. 2020 Mar 14;104:104641 Authors: Fan D, Kang JJ, Fan M, Wang H, Lee A, Yu Y, Chen L, Jillian Tsai C, McBride SM, Riaz N, Gelblum DY, Neal BP, Fetten J, Dunn LA, Michel LS, Boyle JO, Cohen MA, Roman BR, Ganly I, Singh B, Wong RJ, Sherman EJ, Lee NY Abstract OBJECTIVES: Patients with prior irradiated head and neck cancer (HNC)...

pubmed: "oral oncol"[jour]

19h